170503 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants Molecules with a "CD"-designation not provided for elsewhere in
Compositions and methods for diagnosing and treating an inflammation
#902Antibody molecules to PD-1 and uses thereof
#903CELLULAR BLOOD MARKERS FOR EARLY DIAGNOSIS OF ALS AND FOR ALS PROGRESSION
#904Image analysis and measurement of biological samples
#905Method for determining sensitivity to decitabine treatment
#906BIOMARKERS FOR DIAGNOSING AND/OR MONITORING TUBERCULOSIS
#907CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ tregs
#908DETERMINATION OF EFFICIENT TIME(S) FOR CHEMOTHERAPY DELIVERY
#909Modulation of immunity and CEACAM1 activity
#910Methods and kits for determining whether a patient with cirrhosis is at risk of having clinically significant portal hypertension
#911Methods And Marker Combinations For Screening For Predisposition To Lung Cancer
#912Exosome analysis method, exosome analysis apparatus, antibody-exosome complex, and exosome electrophoresis chip
#913Antibodies and conjugates that target misfolded prion protein
#914Anti-mucin antibodies for early detection and treatment of pancreatic cancer
#915Methods to predict progression of Barrett's Esophagus to high grade dysplasia esophageal adenocarcinoma
#916CANCER PROGNOSTIC ASSAYS
#917COMPOSITION FOR DIAGNOSIS OF BEHCET'S DISEASE
#918Method for determining complete response to anticancer therapy
#919CEACAM1 mediated protective immunity
#920Glioblastoma inhibiting compounds and their use
#921BIOLUMINESCENCE IMAGING-BASED SCREENING ASSAY AND INHIBITORS OF ABCG2
#922Antibody against transporter and use thereof
#923Method for detecting injury to the brain
#924METHODS FOR DIAGNOSING AND TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS
#925Kits, compositions and methods for detecting a biological condition
#926MONOCLONAL ANTIBODIES AGAINST NKG2A
#927METHODS FOR DECONTAMINATING CIRCUITS FOR PRODUCING GLUCOSE POLYMERS AND HYDROLYSATES OF GLUCOSE POLYMERS
#928Monoclonal antibodies against NKG2A
#929Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
#930Method of diagnosing and treating infectious disseminated intravascular coagulation
#931METHODS OF MEASURING POTENTIAL FOR THERAPEUTIC POTENCY AND DEFINING DOSAGES FOR AUTOLOGOUS CELL THERAPIES
#932Quantitative determination of biomarkers in the erythrocyte membrane
#933BIOMARKERS FOR ADVERSE CARDIAC REMODELING
#934CD147 as receptor for pilus-mediated adhesion of to vascular endothelia
#935Compositions and methods for treating B-lymphoid malignancies
#936Extracellular matrix metalloproteinase inducer (EMMPRIN) peptides and binding antibodies
#937Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand
#938Composition for diagnosing liver cancer and methods of diagnosing liver cancer and obtaining information for diagnosing liver cancer
#939METHOD OF PROGNOSIS
#940Blocking reagent compositions and methods of making and using the same
#941Method for diagnosis of pulmonary involvement in systemic sclerosis
#942Methods for Increasing Efficacy of CD37-Based Therapy
#943Phosphorothioate oligonucleotide-labeling of white blood cells
#944MECHANISM, DIAGNOSTIC, AND TREATMENTS FOR COMPLICATIONS OF RENAL FAILURE
#945COMPOSITIONS AND METHODS FOR REGULATING HAIR GROWTH
#946COMPOSITION AND KIT FOR SEPARATING CANCER CELL, AND METHOD OF SEPARATING CANCER CELL BY USING THE COMPOSITION AND KIT
#947REGENERATIVE SERA CELLS AND MESENCHYMAL STEM CELLS
#948DIAGNOSTIC METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER
#949PHARMACEUTICAL COMPOSITION AND METHOD FOR IDENTIFYING A CANCEROUS AND/OR AN INFLAMMATORY DISEASE IN A PATIENT
#950Cell-surface signatures for isolating neurons from cell cultures derived from pluripotent stem cells
#951Method for the enumeration of mammalian micronucleated erythrocyte populations, while distinguishing platelets and/or platelet-associated aggregates
#952PARTIAL MHC CONSTRUCTS AND METHODS OF USE
#953Treatment of macrophage-related disorders
#954Method for sorting of pluripotent cells
#955Image analysis and measurement of biological samples
#956KIDNEY FUNCTION BIOMARKERS
#957Toll-like receptor 2 binding epitope and binding member thereto
#958COMPOSITIONS, METHODS AND KITS FOR DIAGNOSING AND TREATING CD206 EXPRESSING CELL-RELATED DISORDERS
#959Method of exosome analysis, reagent for exosome analysis, and analyzer for exosome
#960Method for labeling intracellular and extracellular targets of leukocytes
#961Monoclonal antibody for detecting exosomes
#962METHOD FOR THE PROGNOSIS OF SURVIVAL TIME OF A PATIENT SUFFERING FROM A SOLID CANCER
#963Regulatory T cells and methods of identifying, obtaining and using to treat immuno-based disorders
#964LKB1/STK11 DELETION IN MELANOMA AND RELATED METHODS
#965Method and kit for determining-antibody sensitivity and clone cell strain
#966METHOD FOR DIGANOSING ATHEROSCLEROTIC PLAQUES BY MEASUREMENT OF CD36
#967System for separating a cell sample by centrifugation and column chromatography while maintaining sterility
#968Methods of selecting and treating subjects with low-grade inflammation and metabolic disorders
#969Anti-DLL3 antibody drug conjugates for treating cancer
#970Anti-DLL3 antibody drug conjugates
#971Anti-DLL3 antibodies
#972Methods of detection, diagnosis, and monitoring using anti-DLL3 antibodies
#973Methods for predicting the survival time of a patient suffering from a solid cancer based on density of B cells
#974Anti-DLL3 antibody drug conjugates and methods of use
#975Simultaneous Assay of Target and Target-Drug Binding
#976Acute leukemia and lymphoblastic lymphoma-specific CD43 epitope and use thereof
#977High throughput sensitization detection devices and methods
#978Detection of human somatic cell reprogramming
#979Flow cytometry assay methods
#980Populations of hematopoietic progenitors and methods of enriching stem cells therefor
#981Diagnosis of respiratory tract infectious disease using blood specimens
#982Centrifuge for separating a sample into at least two components
#983Method of diagnosing surgical site infections
#984System and method for capturing and analyzing cells
#985Ovarian cancer stem cells and methods of isolation and uses thereof
#986Methods for establishing and improving the survival of a population of pancreatic progenitor or stem cells
#987Method for increasing number of stem cells in human or animal bodies
#988Diagnosing and treating inflammatory diseases
#989Diagnosis of respiratory tract infectious diseases using urine specimens
#990Use of an anti-CD200 antibody for prolonging the survival of allografts
#991Compositions and methods for diagnosing and treating an inflammation
#992Detection of targets using magnetic resonance
#993Trifunctional crosslinking reagents
#994Method to assess patterns of molecular expression
#995STABILIZATION OF THE ANTI-CD20 ANTIBODY RITUXIMAB
#996URINARY sCD14 AS A BIOMARKER FOR CORONARY ARTERY DISEASE
#997Enrichment and identification of fetal cells in maternal blood and ligands for such use
#998CELL CULTURING FORMULATION AND CULTURING AND QUANTIFICATION METHOD OF CD140B+ CELLS THEREOF
#999Method for detecting low concentrations of specific cell from high concentrations of cell populations, and method for collecting and analyzing detected cell
#1000Oral cancer point of care diagnostics
#1001Method for prediction of prognosis of sepsis
#1002Method for identification and culture of multipotent mesenchymal stem cells with high proliferation potential
#1003Compositions and methods for diagnosing and treating an inflammation
#1004NOVEL METHOD FOR ANALYZING CIRCULATING TUMOR CELLS OF A PATIENT FOR THE PRESENCE OF METASTASIS-INITIATING CELLS
#1005Glycated CD59 peptides, their preparation, and uses thereof
#1006Single chain variable fragment anti-CD133 antibodies and uses thereof
#1007Azapeptides as CD36 binding compounds
#1008Methods and means for diagnosing spondylarthritis using autoantibody markers
#1009Biomarkers of immunomodulatory effects in humans treated with anti-CD200 antibodies
#1010Mobilization of hematopoietic stem cells
#1011Assay for prions
#1012Method for target and drug validation in inflammatory and/or cardiovascular diseases
#1013Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
#1014COMPOSITIONS AND METHODS FOR PROSTATE CANCER ANALYSIS
#1015Anti-CD74 immunoconjugates and methods of use
#1016METHOD FOR PREDICTING THE SURVIVAL STATUS AND PROGNOSIS OF ESOPHAGEAL CANCER AND A KIT THEREOF
#1017Identification and Enrichment of Cell Subpopulations
#1018Compositions and Methods for Characterizing Breast Cancer
#1019NEW METHODS FOR ISOLATING TR1 CELLS
#1020B-cell antigen presenting cell assay
#1021Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
#1022PHENOTYPING TUMOR-INFILTRATING LEUKOCYTES
#1023Sepsis test
#1024Methods for diagnosis, prognosis and methods of treatment
#1025METHOD OF ANALYZING HUMAN sCD14-ST
#1026Compositions and Methods for Diagnosis and Treatment of Breast Cancer
#1027Endoglin antibodies
#1028CANCER STEM CELL MARKERS AND USES THEREOF
#1029METHODS FOR DIAGNOSIS OF IMMUNE RESPONSES AGAINST VIRUSES
#1030METHODS FOR DIAGNOSIS AND TREATMENT OF CUTANEOUS T CELL LYMPHOMAS
#1031Assay for Soluble CD200
#1032RECEPTORS OF RSPO2 AND RSPO3
#1033METHOD OF PROGNOSIS
#1034Human monoclonal antibodies against CD25
#1035MCAM as a biomarker for fluid homeostasis
#1036TIVOZANIB RESPONSE PREDICTION
#1037Methods and materials for treating renal cell carcinoma and glioblastoma multiforme
#1038BIOMARKER FOR DIAGNOSIS, PREDICTION AND/OR PROGNOSIS OF ACUTE HEART FAILURE AND USES THEREOF
#1039IAP BIR domain binding compounds
#1040BIOMARKERS AND METHODS FOR DETERMINING SENSITIVITY TO EPIDERMAL GROWTH FACTOR RECEPTOR MODULATORS
#1041Cosmetic use of lacritin-type polypeptides
#1042METHODS OF IDENTIFYING ANTI-INFLAMMATORY COMPOUNDS
#1043Uses of CD116 Expression Level
#1044Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof
#1045Method and Pharmaceutical Composition for Use in the Treatment of Neurodegenerative Disorders
#1046METHODS FOR IDENTIFYING, ISOLATING, AND UTILIZING ENDOCRINE PROGENITOR CELLS FROM ADULT HUMAN PANCREAS
#1047TREATMENT OF MACROPHAGE-RELATED DISORDERS
#1048Detection/measurement of malaria infection disease utilizing natural immunity by hemozoin induction, screening of preventative or therapeutic medicine for malaria infection disease, and regulation of natural immunity induction
#1049FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsp90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS
#1050Methods for Predicting Cardiovascular Mortality Risk
#1051Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
#1052Method for enumeration of mammalian micronucleated erythrocyte populations, while distinguishing platelets and/or platelet-associated aggregates
#1053Anaplastic Lymphoma Kinase In Kidney Cancer
#1054Anti-CD74 immunoconjugates and methods of use
#1055Software integrated cytometric assay for quantification of the human polymorphonuclear leukocyte FCγRI receptor (CD64)
#1056CD109 POLYPEPTIDES AND USES THEREOF FOR THE TREATMENT OF SKIN CELLS
#1057Methods And Marker Combinations For Screening For Predisposition To Lung Cancer
#1058REGULATORY B CELLS AND THEIR USE
#1059CD93 or use of soluble fragment thereof
#1060COMPOSITION AND METHOD FOR CANCER TREATMENT
#1061CD31 peptides in the treatment of thrombotic and autoimmune disorders
#1062Diagnosis and treatment of breast cancer
#1063MICROFLUIDIC DEVICE FOR CELL SEPARATION AND USES THEREOF
#1064Kit for identifying regulatory T cells
#1065BIOMARKERS FOR THE TREATMENT OF PSORIASIS
#1066PHARMACEUTICAL COMPOSITION AND METHOD FOR IDENTIFYING A CANCEROUS AND/OR AN INFLAMMATORY DISEASE IN A PATIENT
#1067METHOD OF PREDICTING CLINICAL OUTCOMES FOR MELANOMA PATIENTS USING CIRCULATING MELANOMA CELLS IN BLOOD
#1068Compositions and methods for diagnosing and treating an inflammation
#1069Compositions and methods for diagnosing and treating an inflammation
#1070DIFFERENTIATING BETWEEN FIBROSIS AND CIRRHOSIS
#1071Detection of human somatic cell reprogramming
#1072CD37-binding molecules and immunoconjugates thereof
#1073METHODS OF SELECTION OF CELLS FOR TRANSPLANTATION
#1074BIOLUMINESCENCE IMAGING-BASED SCREENING ASSAY AND INHIBITORS OF ABCG2
#1075Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
#1076Polypeptides and antibodies derived from chronic lymphocytic Leukemia cells and uses thereof
#1077Monoclonal Antibodies Against NKG2A
#1078TRP/HIS exchange and kynurenin induced TRP transport
#1079COMPOSITIONS AND METHODS FOR MODULATING CELLS VIA CD14 AND TOLL-LIKE RECEPTOR 4 SIGNALING PATHWAY
#1080METHOD FOR DIAGNOSING ATHEROSCLEROTIC PLAQUES BY MEASUREMENT OF CD36
#1081Assay for analysis of free drug in samples
#1082EX VIVO THERAPEUTICS SCREENING OF LIVING BONE MARROW CELLS FOR MULTIPLE MYELOMA
#1083Compositions and methods for modulating skin pigmentation
#1084Compositions and methods for diagnosing and treating an inflammation
#1085AFFECTING BONE RELATED CONDITIONS USING CD68 BLOCKING AGENTS
#1086COMPOSITIONS AND METHODS RELATING TO DETECTION OF SOLUBLE E-CADHERIN IN NEURODEGENERATIVE DISEASE
#1087METHOD FOR THE DETECTION OF BREAST CANCER BY DETERMINING ALCAM AND/OR BCAM LEVELS IN A PATIENT
#1088Methods for treating chronic lymphocytic leukemia
#1089Chronic lymphocytic leukemia cell line
#1090GM-CSF and truncated CCL2 conjugates and methods and uses thereof
#1091Kit for diagnosis, prognosis, and monitoring the immune status, of patients with chronic inflammatory diseases
#1092Diagnostic method for Alzheimer's disease
#1093ANIMALS WITH REDUCED BODY FAT AND INCREASED BONE DENSITY
#1094Antibodies against CD38 for treatment of multiple myeloma
#1095Method for the identification and separation of non-regulatory T-cells from a mixture of regulatory T-cells
#1096Biomarker for identification of melanoma tumor cells
#1097Method for evaluation of function of phagocyte
#1098Method for enumeration of mammalian micronucleated erythrocyte populations, while distinguishing platelets and/or platelet-associated aggregates
#1099Methods for phenotyping of leukemias
#1100Endoglin antibodies
#1101Anti-CD74 immunoconjugates and methods
#1102Tumor microenvironment of metastasis (TMEM) and uses thereof in diagnosis, prognosis and treatment of tumors
#1103Peripheral zone tumor cells, methods for their preparation and use
#1104Assay for soluble CD200
#1105Baboon homolog of human CD147
#1106Diagnosis and treatment of autism using CD38
#1107Kit for measuring in vivo mutation frequency at an endogenous gene locus
#1108Methods Involving MS4A12 and Agents Targeting MS4A12 for Therapy, Diagnosis and Testing
#1109Mobilization of hematopoietic stem cells
#1110Humanized model of membrane attack complex (MAC) formation on murine retina and compositions, kits and methods for treatment of macular degeneration
#1111Method of detecting leukemic cell
#1112Screening for CD93 (C1qRp)-associated polymorphism(S) in the diagnosis, prevention and treatment of autoimmune diseases
#1113Sample processing system and methods
#1114HUMANIZED ANTI-HUMAN CD34 ANTIBODY, THE PREPARATION METHOD AND USES THEREOF
#1115Centrifuge for separating a sample into at least two components
#1116Blood monocyte CD163 expression as a biomarker in HIV-1 infection and neuroaids
#1117CD36 MODULATION AND USES THEREOF
#1118Method for prenatal diagnosis
#1119Anti-CD74 immunoconjugates and methods of use
#1120IMMUNODEFICIENCY SCREENING AT POINT OF CARE
#1121Crystal structure of CD147 extracellular region and use thereof
#1122Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
#1123IMMUNOTHERAPY BY USING CELL CAPABLE OF CO-EXPRESSING TARGET ANTIGEN AND CD1d AND PULSED WITH CD1d LIGAND
#1124Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
#1125Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
#1126Method of screening endothelial cells for angiogenic capability
#1127LAMININ BINDING SITE
#1128Azapeptides as CD36 binding compounds
#1129NEW BIOMARKER FOR MONITORING DEVELOPMENT OF DISEASES AND ASSESSING THE EFFICACY OF THERAPIES
#1130DIAGNOSTICS AND THERAPEUTICS BASED ON CIRCULATING PROGENITOR CELLS
#1131PROVISION OF NEW CARDIOMYOCYTE PROGENITOR CELLS AND CARDIOMYOCYTES DERIVED THEREFROM
#1132METHODS FOR DIAGNOSING BIOLOGICAL SAMPLES CONTAINING STEM CELLS
#1133PROCESS FOR ENRICHING BASOPHILS IN A BLOOD SAMPLE
#1134Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same
#1135CIRCULATING VE-CADHERIN AS A PREDICTIVE MARKER OF SENSITIVITY OR RESISTANCE TO ANTI-TUMORAL TREATMENT AND IMPROVED METHOD FOR THE DETECTION OF SOLUBLE PROTEINS
#1136METHOD FOR DIAGNOSING ATHEROSCLEROTIC PLAQUES BY MEASUREMENT OF CD36
#1137Method for predicting cancer and other diseases
#1138MELANOMA REPOPULATING CELLS
#1139Methods and kits for early detection of cancer or predisposition thereto
#1140Rhamm, a Co-Receptor and Its Interactions with Other Receptors in Cancer Cell Motility and the Identification of Cancer Prognitor Cell Populations
#1141METHOD FOR DETECTION OF HUMAN PRECURSOR T CELL AND PRECURSOR B CELL
#1142PATHOGEN BINDING
#1143Methods and Composition for Treating Diseases Targeting Prominin-1 (CD133)
#1144Hematopoietic cell phenotyping using circulating cell-free markers
#1145Method for identifying regulatory T cells
#1146Digestive system cancer stem cells and tests and uses therefor
#1147Method for diagnosing and treating Crohn's disease
#1148Lung-Expressed Polypeptides
#1149USE OF SOLUBLE CD160 TO SUPPRESS IMMUNITY
#1150Isolation, expansion and uses of tumor stem cells
#1151Screening method for a substance that binds to an intracellular region of TLR4
#1152Sepsis Test
#1153IDENTIFYING CORONARY OR SOFT TISSUE CALCIFICATION
#1154Quantitative analysis of in vivo mutation at the locus
#1155Modulation of T cell recruitment
#1156Soluble heterodimeric CD94/NKG2 receptors fusion proteins
#1157Methods and Reagents for Preparing and Using Immunological Agents Specific for P-Glycoprotein
#1158LONGEVITY-PROMOTING EFFECTS OF ACETIC ACID AND REISHI POLYSACCHARIDE
#1159METHOD FOR DIAGNOSING AND MONITORING CELLULAR RESERVOIRS OF DISEASE
#1160Facs- and Reporter Protein-Based System for High Throughput Development of Therapeutic Proteins
#1161T CELL ASSAYS
#1162Method for detecting antigen specific or mitogen-activated T cells
#1163Device and methods for detecting a target cell
#1164Monoclonal antibodies against NKG2A
#1165Soluble CD14 antigen
#1166METHODS FOR TESTING ANTI-THROMBOTIC AGENTS
#1167IAP BIR domain binding compounds
#1168CEACAM1 based point-of-care cancer diagnostic
#1169Detection of circulating endothelial cells
#1170Cytotoxicity mediation of cells evidencing surface expression of CD63
#1171Antibodies against CD38 for treatment of multiple myeloma
#1172CD10-activated prodrug compounds
#1173Automated Enumeration and Characterization of Circulating Melanoma Cells in Blood
#1174Anti-CD26 antibodies and methods of use thereof
#1175THERAPY FOR NEUROLOGICAL DISEASES
#1176HUMAN PODOCALYXIN ALTERNATIVE-SPLICED FORMS AND USES THEREOF
#1177Software integrated cytometric assay for quantification of the human polymorphonuclear leukocyte FcγRI receptor (CD64)
#1178Methods for diagnosis prognosis and methods of treatment
#1179Human monoclonal antibodies against CD25
#1180Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
#1181Method of analyzing lymphocytes
#1182ACNE LESION BIOMARKERS AND MODULATORS THEREOF
#1183Detection/Measurement Of Malaria Infection Disease Utilizing Natural Immunity By Hemozoin Induction, Screening Of Preventative Or Therapeutic Medicine For Malaria Infection Disease, And Regulation Of Natural Immunity Induction
#1184Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
#1185Cytotoxicity mediation of cells evidencing surface expression of CD59
#1186Method to Determine Pseudo-Allergic Reactions
#1187Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
#1188Polymorphic Cd24 Genotypes that are Predictive of Multiple Sclerosis Risk and Progression
#1189Methods of Identifying Antibodies to Ligands of Orphan Receptors
#1190Modulation of Muci-Dependent Anti-Estrogen Resistance
#1191Method for enumeration of mammalian micronucleated erythrocyte populations, while distinguishing platelets and/or platelet-associated aggregates
#1192Method of evaluation of the relative risk of developing atherosclerosis in patients
#1193Cd4+ Cd25+ T-cells activated to a specific antigen
#1194Cancer Test
#1195Stem Cells, Method For Their Purification, Identification, and Use
#1196Compounds that Block the C5a Receptor and Their Use in Therapy
#1197Methods for identifying, isolating, and utilizing endocrine progenitor cells from adult human pancreata
#1198Trp/his exchange and kynurenine induced Trp transport
#1199Use of the salivary protein CD14 as an indicator of the low risk to developing dental caries
#1200Anti-CD63 antibodies and methods of use thereof